Lv11
18 积分 2024-08-19 加入
Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus
3小时前
已完结
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos
8小时前
已完结
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
22天前
已完结
Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders
26天前
已完结
Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report
1个月前
已完结
Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project
1个月前
已完结
A Bayesian dose‐finding design for drug combination clinical trials based on the logistic model
1个月前
已完结
PARP Inhibitor Plus Androgen Receptor Pathway inhibitor combinations for 1st line mCRPC: A systematic review and meta-analysis
1个月前
已完结
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
2个月前
已完结
Identifying patients with NTRK fusion cancer
2个月前
已完结
皖公网安备34019202002308
